All news articles for August 2012

Hospira, API, India

Hospira adds antibiotic API capacity in India

By Natalie Morrison

Hospira has bought Orchid Chemicals and Pharmaceutical’s active pharmaceutical ingredient (API) facility in Aurangabad, India, to support its expanding antibiotic business.

PRA talks about expansion in China

PRA talks about expansion in China

By Gareth Macdonald

The lack of competing studies, proximity to the SFDA HQ and were the key drivers for the new Beijing, China office according to PRA International. 

United Drug buys DSA and Synpoia

United Drug buys DSA and Synpoia

United Drug (UD) has bought firms in the pharmacovigilance and market access sectors, following up on its acquisition in the contract packaging industry last week.

BE/BA, FDA, bioRASI, GDUFA

BE/BA sites must be logged with US FDA under GDUFA

By Gareth Macdonald

CROs conducting bioequivalence and bioavailability (BE/BA) studies for generics firms will have to log details of their sites with the US FDA under new ‘self-identification’ rules.